Mariagiovanna Cantone

Dr. Mariagiovanna Cantone

A.O.U. Gaspare Rodolico Policlinico-San Marco, Catania, Sicilia, Italy
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 August 2014 in Clinical Neurophysiology
Verified
Journal Article
Closed access
Mariagiovanna CantoneMariagiovanna Cantone
Mariagiovanna Cantone
GPGiovanni Di Pino
Giovanni Di Pino
FCFioravante Capone
Fioravante Capone
MPMarianna Piombo
Marianna Piombo
DCDaniela Chiarello
Daniela Chiarello
VLVincenzo Di Lazzaro
Vincenzo Di Lazzaro

20 November 2014 in International Journal of Psychiatry in Clinical Practice
Verified
Journal Article
Closed access
PDF file
Carmen ConcertoCarmen Concerto
Carmen Concerto
Giuseppe LanzaGiuseppe Lanza
Giuseppe Lanza
Mariagiovanna CantoneMariagiovanna Cantone
Mariagiovanna Cantone
RFRaffaele Ferri
Raffaele Ferri
GPGiovanni Pennisi
Giovanni Pennisi
EAEugenio Aguglia
Eugenio Aguglia
Objective. In this study we aimed to assess the long-term efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) on depressive symptoms and cognitive performance in patients with drug-resistant major depressive disorder (MDD). Methods. Fifteen drug-resistant depressed outpatients completed an acute trial with augmentative high-frequency rTMS over the left dorsolateral prefrontal cortex (DLPFC) and were compared with 15 drug-resistant MDD patients who underwent sham procedure. Depressive symptoms were evaluated with the Hamilton Depression Rating Scale and Montgomery–Asberg Depression Rating Scale. The Frontal Assessment Battery and the Stroop Color–Word Test Interference (Stroop T) were used to probe executive functions. Outcome measures were obtained at baseline, 4 weeks after the rTMS, as well as 3 months and 6 months after the end of the stimulation protocol. Results. After the active rTMS, patients showed a significant decrease in the scores at the depression rating scales that lasted for 6 months. A transient improvement was also observed at the Stroop T, although it did not persist in time. Conclusions. High-frequency rTMS over the left DLPFC may have long-term antidepressant effect in drug-resistant MDD. TMS is a valuable tool for the add-on treatment of mood disorders and for the design of customized stimulation protocols.

1 May 2017 in ASN Neuro
Verified
Journal Article
Open access
Mariagiovanna CantoneMariagiovanna Cantone
Mariagiovanna Cantone
ABAlessia Bramanti
Alessia Bramanti
Giuseppe LanzaGiuseppe Lanza
Giuseppe Lanza
MPManuela Pennisi
Manuela Pennisi
PBPlacido Bramanti
Placido Bramanti
RBRita Bella
Rita Bella
Neural plasticity is considered the neurophysiological correlate of learning and memory, although several studies have also noted that it plays crucial roles in a number of neurological and psychiatric diseases. Indeed, impaired brain plasticity may be one of the pathophysiological mechanisms that underlies both cognitive decline and major depression. Moreover, a degree of cognitive impairment is frequently observed throughout the clinical spectrum of mood disorders, and the relationship between depression and cognition is often bidirectional. However, most evidence for dysfunctional neural plasticity in depression has been indirect. Transcranial magnetic stimulation has emerged as a noninvasive tool for investigating several parameters of cortical excitability with the aim of exploring the functions of different neurotransmission pathways and for probing in vivo plasticity in both healthy humans and those with pathological conditions. In particular, depressed patients exhibit a significant interhemispheric difference in motor cortex excitability, an imbalanced inhibitory or excitatory intracortical neurochemical circuitry, reduced postexercise facilitation, and an impaired long-term potentiation-like response to paired-associative transcranial magnetic stimulation, and these symptoms may indicate disrupted plasticity. Research aimed at disentangling the mechanism by which neuroplasticity plays a role in the pathological processes that lead to depression and evaluating the effects of modulating neuroplasticity are needed for the field to facilitate more powerful translational research studies and identify novel therapeutic targets.

12 May 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
MPManuela Pennisi
Manuela Pennisi
Giuseppe LanzaGiuseppe Lanza
Giuseppe Lanza
Mariagiovanna CantoneMariagiovanna Cantone
Mariagiovanna Cantone
EDEmanuele D'amico
Emanuele D'amico
FFFrancesco Fisicaro
Francesco Fisicaro
Giulia MalaguarneraGiulia Malaguarnera
Giulia Malaguarnera
Several studies explored the effects of acetyl-L-carnitine (ALC) in dementia, suggesting a role in slowing down cognitive decline. Nevertheless, in 2003 a systematic review concluded there was insufficient evidence to recommend a clinical use, although a meta-analysis in the same year showed a significant advantage for ALC for clinical scales and psychometric tests. Since then, other studies have been published; however, a critical review is still lacking. We provide an update of the studies on ALC in primary and secondary dementia, highlighting the current limitations and translational implications. Overall, the role of ALC in dementia is still under debate. The underlying mechanisms may include restoring of cell membranes and synaptic functioning, enhancing cholinergic activity, promoting mitochondrial energy metabolism, protecting against toxins, and exerting neurotrophic effects. The effects of ALC on the gut–liver–brain axis seem to identify the category of patients in which the new insights contribute most to the mechanisms of action of ALC, likely being the liver metabolism and the improvement of hepatic detoxifying mechanisms the primary targets. In this framework, our research group has dealt with this topic, focusing on the ALC-related cross-talk mechanisms. Further studies with homogeneous sample and longitudinal assessment are needed before a systematic clinical application.

1 January 2018 in Therapeutic Advances in Neurological Disorders
Verified
Journal Article
Open access
Giuseppe LanzaGiuseppe Lanza
Giuseppe Lanza
Mariagiovanna CantoneMariagiovanna Cantone
Mariagiovanna Cantone
DADebora Aricò
Debora Aricò
BLBartolo Lanuzza
Bartolo Lanuzza
FCFilomena Irene Ilaria Cosentino
Filomena Irene Ilaria Cosentino
RFRaffaele Ferri
Raffaele Ferri
Background: Based on the hyperexcitability and disinhibition observed in patients with restless legs syndrome (RLS) following transcranial magnetic stimulation (TMS), we conducted a study with low-frequency repetitive TMS (rTMS) over the primary motor (M1) and somatosensory cortical areas (S1) in patients with RLS. Methods: A total of 13 right-handed patients and 10 age-matched controls were studied using clinical scales and TMS. Measurements included resting motor threshold (rMT), motor-evoked potentials (MEPs), cortical silent period (CSP), and central motor conduction time (CMCT). A single evening session of rTMS (1 Hz, 20 trains, 50 stimuli each) was administered over the left M1, left S1, and sham stimulation over M1 in a random order. Clinical and TMS measures were repeated after each stimulation modality. Results: Baseline CSP was shorter in patients than in controls and remained shorter in patients for both motor and somatosensory stimulation. The patients reported a subjective improvement of both initiating and maintaining sleep the night after the rTMS over S1. Patients exhibited a decrease in rMT after rTMS of S1 only, although the effect was smaller than in controls. MEP latency and CMCT changed only in controls after stimulation. Sham stimulation was without effect on the observed variables. Conclusions: rTMS on S1-M1 connectivity alleviated the sensory–motor complaints of RLS patients. The TMS indexes of excitation and inhibition indicate an intracortical and corticospinal imbalance, mainly involving gamma-aminobutyric acid (GABA)ergic and glutamatergic circuitries, as well as an impairment of the short-term mechanisms of cortical plasticity. The rTMS-induced activation of the dorsal striatum with the consequent increase of dopamine release may have contributed to the clinical and neurophysiological outcome.